Episode
Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
- Podcast
- Hematologic Oncology Update
- Published
- Nov 15, 2025
- Duration seconds
- 3582
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/patient-education-resource-non-hodgkin-lymphoma-clinical-experts-address-common-questions-posed-by-patients-about-car-t-cell-therapy/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hematologic-oncology-update-916423/patient-education-resource-non-hodgkin-lymphoma-clinical-experts-address-common-questions-posed-by-patients-about-car-t-cell-therapy.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Manali Kamdar from the University of Colorado Cancer Center in Aurora discuss patient questions and experiences with CAR T-cell therapy for non-Hodgkin lymphoma. Educational information and select publications here .